Volume : 13, Issue : 07, July – 2026

Title:

IMPLEMENTATION OF DATA INTEGRITY PRINCIPLES IN PHARMACEUTICAL QUALITY ASSURANCE

Authors :

Sayed Shaffath Ali, Neeradi Anusha, Dr. Shaik shabeer, Dr. P.Poli Reddy

Abstract :

In the pharmaceutical world, the maintaining of data integrity represents one of the most critical aspects of ensuring that medications reach patients safely and effectively. This concept goes far beyond simple record keeping it encompasses the entire journey of information from initial research through final product delivery, ensuring that every piece of data remains accurate, reliable, complete, and consistent throughout this process. The regulatory landscape has evolved significantly, with organizations like the FDA establishing comprehensive guidelines such as 21 CFR Part 11, alongside internationally recognized frameworks like ALCOA+ and ICH Q7. These standards emphasize that pharmaceutical data must be attributable, legible, contemporaneous, original, and accurate, while also being complete, consistent, enduring, and available whenever needed. The importance of data integrity extends well beyond regulatory compliance. When pharmaceutical companies maintain robust data practices, they build trust with patients, protect public health, and foster transparency across all operational levels. However, the path to achieving this ideal is fraught with challenges, including human errors, inadequate digital infrastructure, poor documentation practices, and increasingly sophisticated cybersecurity threats. To address these challenges, companies are implementing comprehensive risk-based approaches, investing in advanced digital technologies, and cultivating organizational cultures that prioritize quality and accountability. This paper explores the fundamental principles governing data integrity, examines regulatory requirements, identifies common pitfalls, and presents best practices for maintaining data integrity in pharmaceutical operations. Modern technologies like automation, artificial intelligence, and block chain further strengthen data security and traceability.

Cite This Article:

Please cite this article in press Sayed Shaffath Ali et al., Implementation Of Data Integrity Principles In Pharmaceutical Quality Assurance, Indo Am. J. P. Sci, 2026; 13(07).

REFERENCES:

1. Divya Gokulakrishnan, Sowmyalakshmi Venkataraman, Ensuring data integrity: bestpractices and strategies in pharmaceutical industry, Intelligent Pharmacy, 2025, Vol.3 No.4. ISSN:2949-866X, Pg No:296-303.
2. https://www.perplexity.ai/search/please-provide-the-
pharmaceutiRv6NQS5BTcyWwPJulSZt1gretriveon2-05-2026.
3. Shmmon Ahmad, Ashok Kumar and Dr. Abdul Hafeez, The pharma innovation, Importance of Data Integrity & Its Regulation in PharmaceuticalIndustry,2019,ISSN(E)2277-7695,ISSN(P)2349-8242, PgNo:306-313.
4. Madhanraj S, Anton Smith A, ata integrity in pharmaceuticals, InternationalJournalofDrugRegulatoryAffairs,2025,ISSN:2321-6794, Page No 26-36.
5. Shmmon Ahmad, Ashok Kumar and Dr. Abdul Hafeez, The pharma innovation, Importance of Data Integrity & Its Regulation in PharmaceuticalIndustry,2019,ISSN(E)2277-7695,ISSN(P)2349-8242, PgNo:306-313.
6. Madhanraj S, Anton Smith A, ata integrity in pharmaceuticals, InternationalJournalofDrugRegulatoryAffairs,2025,ISSN:2321-6794, Page No 26-36.
7. SanketGade,Dr.PreranaJadhav,Dr.PradyumanaIge,PratikshaBornare, Data integrity compliance, importance, consequences and strategy to overcome data integrity in the pharmaceutical industry, International Journal Of Pharmaceutical Sciences ,2024, Vol 02.
8. Divya Gokulakrishnan, Sowmyalakshmi Venkataraman, Ensuring data integrity:bestpracticesandstrategiesinpharmaceuticalindustry, IntelligentPharmacy,2025,Vol.3No.4.ISSN:2949-866X,PgNo:296-303.
9. P. KirubaRachel, N.VishalGupta, DataIntegrityRegulations&Current Scenario, 2017, ISSN: 0976-044X, Pg No: 16-22.Shmmon Ahmad, Ashok Kumar, Abdul Hafeez, Importance of data integrity & its regulation in pharmaceutical industry, Pharma Innovation Journal ,2018, Pg No: 306-313.
10. Shmmon Ahmad, Ashok Kumar and Dr. Abdul Hafeez, The pharma innovation, Importance of Data Integrity & Its Regulation in PharmaceuticalIndustry,2019,ISSN(E)2277-7695,ISSN(P)2349- 8242, PgNo:306-313.

11. Manoj Kumar Suryakant Bhadrashette, Over view of data integrityissuesinpharmaceuticalindustry,InternationalJournalofPharmaceutical Sciences Review & Research,2018, ISSN 0976 –044X , Article No. 14, Pages: 95-101.
12. Anil K. Rattan, Data Integrity: History, Issues & remediation of Issues, 2018.

13. AdjunctAssociateProfessorSiaChongHock,ChanLaiWah,VernonTay, Vimal Sachdeva, Pharmaceutical DI: Issues, Challenges& Proposed solutions for manufacturers & inspectors, 2020, Vol 9.
14. Vignesh. M, Ganesh G.N.K, Current status, challenges & preventives strategiestoovercomeDIissuesinthepharmaceuticalindustry,2020,Vol 12, ISSN: 0975-7058.
15. Mohammad Zarour, Mamdough Alenezi, Md Tarique Jamal Ansari, Abhishek Kumar Pandey, Massod Ahmad Khan, Alka Agarwal, Rajeev Kumar, Raees Ahmed Khan, Ensuring data integrity of healthcare information in the era of digital health, 2021.
16. Dharnesh. R, Jeyaprakash M.R, An Approach of Data Integrity in Pharmaceutical Industries, 2022.
17. Naseem A. Charoo, Mansoor A. Khan, Ziyaur Rahman, Data Integrity IssuesInPharmaceuticalIndustry: CommonObservations, Challenges & Mitigations Strategies, 2023.
18. M H Ingale, M C Tayade, Y P Patil, Rahul Salunkhe, Data Integrity Violations in the Pharmaceutical Industry and Regulatory Measures, Internation Journal of Pharmaceutical Quality Assurance ,2023, Pg No: 416-420.
19. KamarajA, Sangamesh Puranik, DI & Meeting the Regulatory Expectations, 2023, Vol 24.
20. Saad Khan, Dania Mohsin Khan, Implementing DI As a Code: Step by Step Guide for Clinical Trials, 2023.SnehalChandrashekhar Jale*, NidheeVinayakTendulkar, SiddhiMaruti Chavan, Sayali Venkat Biradar, Jayshree Kishor Sonawane, Ishwari PrakashNarkar,AayeshaDashrathBargeVaishaliJadhav,DrAshishJain2023, ISSN2582-7421.
21. Snehal Chandrashekhar Jale*, Nidhee Vinayak Tendulkar, Siddhi Maruti Chavan, Sayali Venkat Biradar, Jayshree Kishor Sonawane, Ishwari Prakash Narkar, Aayesha Dashrath Barge, Vaishali Jadhav, Dr Ashish Jain , 2023, ISSN 2582-7421.
22. Sasidhar Duggineni, Data Integrity & risk, 2023.
23. Mrunal M .Sabel, Varun A. Pande, Amol A. Tagallpallewar, Arti G. Swami, Anil. Pawar, Akshay M. Baheti, Maintaining Data Safety & ACCURACY Through Data Integrity (DI): A Comprehensive Review, 2024, Vol 17.
24. Sanket Gade, Prerana Jadav, Pradyumana Ige, Pratiksha Bornare, DI Compliance, Importance, Consequences & Strategy to Overcome DI In ThePharmaceutical Industry, 2024, Vol 2, ISSN: 0975-4725.
25. Pravin Ullagaddi, Safeguarding Data Integrity in Pharmaceutical Manufacturing, Journal of Advices in Medical and Pharmaceutical Sciences, 2024, ISSN: 2394-1111, Vol: 26, Pg No: 64-75.
26. Akshya U. Bhandarkar, Balaji J, Jasvanth R., Dinesh Ragavendra S., Ensuring DI In Pharmaceutical Industry: Benefits, Challenges, Key Considerations & Best Practices, 2024, Vol 2, ISSN: 0975-4725.
27. ArunAyilliathKeezhabadath,LalithaAmarapalli,EnsuringDataIntegrity inPharmaceuticalQualitySystems:ARisk –BasedApproach, Journalof AI – Powered Medical Innovations.
28. Priti Sanjay Pagar, Mahesh Kailas Wagh, Suraj Sanjay Shelar, Data Integrity Challenges In Pharmaceutical QA And Their Solutions, International Journal of Creative ResearchThoughts, 2025, ISSN: 2320-2882, Vol: 13.
29. Patel Richi & Rajgor Hiral A, DI in PharmaceuticalQualitySystem, 2025, Vol 2.
30. Chanchal Manohar Avchar, Ensuring Data Integrity InThe Pharmaceutical Industry: Challenges & Best Practices, International Journal of Pharmaceutical Science, 2025, Vol 3.
31. Madhanraj S, Anton Smith A, Data integrity in pharmaceuticals, InternationalJournalofDrugRegulatoryAffairs,2025,ISSN:2321-6794, Page No 26-36.
32. FirozMohammedOzman,Systematicliteraturereviewonthecriticalrole of data integrity in AI-driven enterprises, 2025, ISSN: 2582-8266.
33. GregorMiller,ElmarSpigel,GuidelinesforResearchDI(GRDI),2025.
34. GaikwadSwapnali,GaiwalSanika,GhodkePratiksha,GhorpadeIshwari, Gire Nishigandha, Dr. S. D. Mankar, Review on Data IntegrityBased on The Principles Of ALCOA, 2025.
35. Tapamoy Chakraborty, Data Integrity Principles ALCOA+++ Contents, 2025.
36. BiswalShreyaAiay& Chhaya U Shah, Data IntegrityIn Pharmaceutical QualityAssurance:AReview Based onALCOAPrinciples, 2026, Vol8.
37. Buddaraju Vivekananda Raju1, B. Babu, Smita Jain3, JanoriousWinka Jayaprakash4, Jayaprakash Narayanan Jaganathan5, Nagarajan Janaki Sankarachari Krishnana, Evaluating Data Integrity Issues in the Pharmaceutical Industry and Proposing Solutions Through the Pharmaceutical Education Curriculum, 2026, Vol 16.
38. Pravin Ullagaddi, Safeguarding Data Integrity in Pharmaceutical Manufacturing, Journal of Advices in Medical and Pharmaceutical Sciences, 2024 ,ISSN : 2394-1111 ,Vol:26 , Pg No: 64-75.
39. https://pharmadigests.com/objective-of-data-management-and-integrityretriveon3-05-2026.
40. Madhanraj S, Anton Smith A, ata integrity in pharmaceuticals, InternationalJournalofDrugRegulatoryAffairs,2025,ISSN:2321-6794, Page No 26-36.